Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
Outline of Final Research Achievements |
To obtain more mature iPS induced hepatocyte like cells, we investigated a novel protocol by using mesenchymal stem cells and decellularized liver matrix. Mesenchymal stem cells and decellularized liver matrix could enhance the hepatic function of human iPSC-derived hepatocyte-like cells. However, these cells have immature function compared to primary hepatocyte. More technological innovations are needed to clinical application.
|